Thiotepa
Top View
- A Feasibility Study of Multiple Cycle Therapy with Melphalan, Thiotepa
- Bladder Cancer: Current Optimal O N Intravesical Treatment T I Donald L
- DRUG NAME: Thiotepa
- Four-Cycle High-Dose Therapy with Hematopoietic Support for Metastatic Breast Cancer: No Improvement in Outcomes Compared with Single-Course High-Dose Therapy
- Emetogenic Potential of Antineoplastic Agents
- Handling Cytostatic Drugs: Contents
- A New Multidrug Reinduction Protocol with Topotecan, Vinorelbine
- Chemotherapy Protocol LYMPHOMA Matrix
- Thiotepa (Thioplex®) (“THYE‐Oh‐TEP‐A”)
- Safety and Efficacy of Thiotepa-Based Conditioning for Allogeneic Transplantation in AML: a Survey from the ALWP of the EBMT
- A Phase IIA Study of the Addition of Temozolomide
- Hematopoietic Stem Cell Transplantation in Thalassemia Major and Sickle Cell Disease: Indications and Management Recommendations from an International Expert Panel
- Oncology Medications Policy (1403)
- Breast Cancer High-Dose Thiotepa, Melphalan and Carboplatin
- Therapeutic Polymeric Nanoparticle Compositions
- Effects of Fluorouracil and Fluorouridine on Protein Synthesis in Rabbit Retina
- Changes Produced in the Urothelium by Traditional and Newer Therapeutic
- Thiotepa for Injection, Usp